USPTO trademark

VISTAGEN

AllowedUSPTOWord markClass 5

"VISTAGEN" is a word mark owned by VistaGen Therapeutics, Inc., filed at the USPTO on May 27, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

Official USPTO record
VISTAGEN trademark as filed
As filed with the USPTO
Status
Allowed
Since June 8, 2026
Filed
May 27, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99203964
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns VISTAGEN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services VISTAGEN is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in the area of mental health care and the treatment of central nervous system diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 1 granted
  3. Sou extension 1 filed
  4. Sou teas extension received
  5. Assigned to examiner
  6. Noa e-mailed - sou required from applicant
  7. Official gazette publication confirmation e-mailed
  8. Published for opposition
  9. Notification of notice of publication e-mailed
  10. Approved for pub - principal register

4 earlier steps on the official record.

FAQ

About VISTAGEN

Who owns the trademark "VISTAGEN"?

The USPTO trademark "VISTAGEN" (application 99203964) is owned by VistaGen Therapeutics, Inc.

What is the status of "VISTAGEN"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VISTAGEN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2ad0-2c21-7327-a251-e105b8dbeca2
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ad0-2c21-7327-a251-e105b8dbeca2",
  "object": "trademark",
  "mark_text": "VISTAGEN",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99203964",
  "filing_date": "2025-05-27",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "VistaGen Therapeutics, Inc.",
      "entity_id": "ent_019eb702-dbf7-71cd-a740-23e4c8ddde0c"
    }
  ]
}